U.S. drug prices don't translate to better health

Americans pay more than other countries do for prescription drugs, and see quicker drug approvals — but not necessarily better health outcomes, according to several studies. Why it matters: As Washington debates the administration’s new Medicare drug pricing proposal, the pharmaceutical industry says high U.S. drug prices are justified because we have better access to new drugs.